SYSTEMIC HEALTH EFFECTS ASSOCIATED WITH SODIUM ARSENITE EXPOSURE: A REAPPRAISAL

S ASHRAF; A TAHIR; A AMJAD; S HAMEED; R IMTIAZ; A SHABBIR; R SHEHZADI

doi:10.54112/bcsrj.v2023i1.601

Authors

S ASHRAF University of Sialkot, Sialkot, Pakistan
A TAHIR University of Sialkot, Sialkot, Pakistan
A AMJAD University of Sialkot, Sialkot, Pakistan
S HAMEED University of Sialkot, Sialkot, Pakistan
R IMTIAZ University of Sialkot, Sialkot, Pakistan
A SHABBIR University of Sialkot, Sialkot, Pakistan
R SHEHZADI University of Sialkot, Sialkot, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.601

Keywords:

Exposure, Health, Mechanism, Sodium Arsenite, System

Abstract

Sodium Arsenite is a potent toxic mutagenic and xenobiotic metalloid that has been increasing in the environment as a significant pollutant. Contamination of drinking water by chemicals containing arsenic is still a serious public health issue. Prolonged exposure to sodium arsenite can lead to several health problems, including irregularities in the cardiovascular system, diabetes, nephrotoxicity, neurotoxicity, hearing loss, haematological diseases, hepatotoxicity, and infertility. Sodium arsenite is a multi-site carcinogen that can cause cancers in the skin, kidney, colon, lung, and uterus, among other tissues. Numerous research investigations have demonstrated that the toxicity of arsenic is contingent upon various elements such as exposure level, frequency, duration, biological species, age, gender, genetic susceptibilities, and nutritional status. Arsenic exposure has been linked to several consequences, such as apoptosis, cell growth, and alteration of signal transduction pathways. This implies that Arsenite might have incredibly wide impacts rather than targeted effects. Furthermore, several epidemiological studies have documented the exposure sources and the worldwide impacts of arsenic, but the exact method by which it affects various systems, including cancer, is still unknown. More research is needed to give a more precise knowledge of the underlying mechanism.

Downloads

Download data is not yet available.

References

Amankwah, S. A., and Fasching, J. L. (1985). Separation and determination of arsenic (V) and arsenic (III) in sea-water by solvent extraction and atomic-absorption spectrophotometry by the hydride-generation technique. Talanta 32, 111-114.

Aposhian, H. V., Gurzau, E. S., Le, X. C., Gurzau, A., Healy, S. M., Lu, X., Ma, M., Yip, L., Zakharyan, R. A., and Maiorino, R. M. (2000). Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chemical Research in Toxicology 13, 693-697.

Armstrong, C. W., Stroube, R. B., Rubio, T., Siudyla, E. A., and Miller, G. B. (1984). Outbreak of fatal arsenic poisoning caused by contaminated drinking water. Archives of Environmental Health: An International Journal 39, 276-279.

Aschengrau, A., Zierler, S., and Cohen, A. (1989). Quality of community drinking water and the occurrence of spontaneous abortion. Archives of Environmental Health: An International Journal 44, 283-290.

Bardullas, U., Limón-Pacheco, J., Giordano, M., Carrizales, L., Mendoza-Trejo, M., and Rodríguez, V. (2009). Chronic low-level arsenic exposure causes gender-specific alterations in locomotor activity, dopaminergic systems, and thioredoxin expression in mice. Toxicology and Applied Pharmacology 239, 169-177.

Blom, S., Lagerkvist, B., and Linderholm, H. (1985). Arsenic exposure to smelter workers: clinical and neurophysiological studies. Scandinavian journal of work, environment & health, 265-269.

Borgoño, J. M., Vicent, P., Venturino, H., and Infante, A. (1977). Arsenic in the drinking water of the city of Antofagasta: epidemiological and clinical study before and after the installation of a treatment plant. Environmental Health Perspectives 19, 103-105.

Börzsönyi, M., Bereczky, A., Rudnai, P., Csanady, M., and Horvath, A. (1992). Epidemiological studies on human subjects exposed to arsenic in drinking water in southeast Hungary. Archives of Toxicology 66, 77-78.

Chaudhuri, A. N., Basu, S., Chattopadhyay, S., and Gupta, S. D. (1999). Effect of high arsenic content in drinking water on rat brain.

Chen, C.-J., Hsu, L.-I., Wang, C.-H., Shih, W.-L., Hsu, Y.-H., Tseng, M.-P., Lin, Y.-C., Chou, W.-L., Chen, C.-Y., and Lee, C.-Y. (2005). Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan. Toxicology and applied pharmacology 206, 198-206.

Chiou, J.-M., Wang, S.-L., Chen, C.-J., Deng, C.-R., Lin, W., and Tai, T.-Y. (2005). Arsenic ingestion and increased microvascular disease risk: observations from the south-western arseniasis-endemic area in Taiwan. International journal of epidemiology 34, 936-943.

Cifuentes, F., Bravo, J., Norambuena, M., Stegen, S., Ayavire, A., and Palacios, J. (2009). Chronic exposure to arsenic in tap water reduces acetylcholine-induced relaxation in the aorta and increases oxidative stress in female rats. International journal of toxicology 28, 534-541.

Concha, G., Vogler, G., Lezcano, D., Nermell, B., and Vahter, M. (1998). Exposure to inorganic arsenic metabolites during early human development. Toxicological sciences 44, 185-190.

Datta, D., Mitra, S., Chhuttani, P., and Chakravarti, R. (1979). Chronic oral arsenic intoxication as a possible aetiological factor in idiopathic portal hypertension (non-cirrhotic portal fibrosis) in India. Gut 20, 378-384.

Dhar, P., Mohari, N., and Mehra, R. D. (2007). Preliminary morphological and morphometric study of rat cerebellum following sodium arsenite exposure during rapid brain growth (RBG) period. Toxicology 234, 10-20.

Edmondson, J. C., Liem, R., Kuster, J. E., and Hatten, M. E. (1988). Astrotactin: a novel neuronal cell surface antigen that mediates neuron-astroglial interactions in cerebellar microcultures. The Journal of cell biology 106, 505-517.

ENTERLINE, P. E., and MARSH, G. M. (1982). Cancer among workers exposed to arsenic and other substances in a copper smelter. American journal of epidemiology 116, 895-911.

Farias, P., Espírito Santo, C., Branco, R., Francisco, R., Santos, S., Hansen, L., Sorensen, S., and Morais, P. V. (2015). Natural hot spots for gain of multiple resistances: arsenic and antibiotic resistances in heterotrophic, aerobic bacteria from marine hydrothermal vent fields. Applied and environmental microbiology 81, 2534-2543.

Felix, K., Manna, S. K., Wise, K., Barr, J., and Ramesh, G. T. (2005). Low levels of arsenite activates nuclear factor‐κB and activator protein‐1 in immortalized mesencephalic cells. Journal of biochemical and molecular toxicology 19, 67-77.

Flora, S. J., Bhadauria, S., Pant, S. C., and Dhaked, R. K. (2005). Arsenic induced blood and brain oxidative stress and its response to some thiol chelators in rats. Life sciences 77, 2324-2337.

Flora, S. J., Mehta, A., and Gupta, R. (2009). Prevention of arsenic-induced hepatic apoptosis by concomitant administration of garlic extracts in mice. Chemico-biological interactions 177, 227-233.

Fowler, B. A., and Weissberg, J. B. (1974). Arsine poisoning. New England Journal of Medicine 291, 1171-1174.

Geneva, W., and Organization, W. H. (1999). Back to cited text no. 17.

Ghosh, S., Mishra, R., Biswas, S., Bhadra, R. K., and Mukhopadhyay, P. K. (2017). α-Lipoic acid mitigates arsenic-induced hematological abnormalities in adult male rats. Iranian journal of medical sciences 42, 242.

Giberson, A., Vaziri, N. D., Mirahamadi, K., and Rosen, S. (1976). Hemodialysis of acute arsenic intoxication with transient renal failure. Archives of internal medicine 136, 1303-1304.

Guha Mazumder, D. N., De, B. K., Santra, A., Ghosh, N., Das, S., Lahiri, S., and Das, T. (2001). Randomized placebo-controlled trial of 2, 3-dimercapto-1-propanesulfonate (DMPS) in therapy of chronic arsenicosis due to drinking arsenic-contaminated water. Journal of Toxicology: Clinical Toxicology 39, 665-674.

Harris, G. K., and Shi, X. (2003). Signaling by carcinogenic metals and metal-induced reactive oxygen species. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 533, 183-200.

Hernández-Zavala, A., Del Razo, L. M., Aguilar, C., Garcı́a-Vargas, G. G., Borja, V. H., and Cebrián, M. E. (1998). Alteration in bilirubin excretion in individuals chronically exposed to arsenic in Mexico. Toxicology Letters 99, 79-84.

Hsueh, Y.-M., Wu, W.-L., Huang, Y.-L., Chiou, H.-Y., Tseng, C.-H., and Chen, C.-J. (1998). Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure. Atherosclerosis 141, 249-257.

Hughes, M. F., Beck, B. D., Chen, Y., Lewis, A. S., and Thomas, D. J. (2011). Arsenic exposure and toxicology: a historical perspective. Toxicological sciences 123, 305-332.

Ishrath, A., Kumar, N., and Dey, C. S. (2002). Differential activation of ERK and JNK by arsenite in mouse muscle cells. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 132, 375-384.

Jacobson-Kram, D., and Montalbano, D. (1985). Reproductive Effects Assessment Group's report on the mutagenicity of inorganic arsenic. Environ. Mutagen.;(United States) 7.

Jain, A., Yadav, A., Bozhkov, A., Padalko, V., and Flora, S. (2011). Therapeutic efficacy of silymarin and naringenin in reducing arsenic-induced hepatic damage in young rats. Ecotoxicology and environmental safety 74, 607-614.

Järup, L. (2003). Hazards of heavy metal contamination. British medical bulletin 68, 167-182.

Kimura, A., Ishida, Y., Hayashi, T., Wada, T., Yokoyama, H., Sugaya, T., Mukaida, N., and Kondo, T. (2006). Interferon-γ plays protective roles in sodium arsenite-induced renal injury by up-regulating intrarenal multidrug resistance-associated protein 1 expression. The American journal of pathology 169, 1118-1128.

Klein, C. B., Leszczynska, J., Hickey, C., and Rossman, T. G. (2007). Further evidence against a direct genotoxic mode of action for arsenic-induced cancer. Toxicology and applied pharmacology 222, 289-297.

Kokilavani, V., Devi, M. A., Sivarajan, K., and Panneerselvam, C. (2005). Combined efficacies of dl-α-lipoic acid and meso 2, 3 dimercaptosuccinic acid against arsenic induced toxicity in antioxidant systems of rats. Toxicology letters 160, 1-7.

Krüger, K., Straub, H., Hirner, A. V., Hippler, J., Binding, N., and Muβhoff, U. (2009). Effects of monomethylarsonic and monomethylarsonous acid on evoked synaptic potentials in hippocampal slices of adult and young rats. Toxicology and applied pharmacology 236, 115-123.

Lee, M.-Y., Lee, Y.-H., Lim, K.-M., Chung, S.-M., Bae, O.-N., Kim, H., Lee, C.-R., Park, J.-D., and Chung, J.-H. (2005). Inorganic arsenite potentiates vasoconstriction through calcium sensitization in vascular smooth muscle. Environmental Health Perspectives 113, 1330-1335.

Liu, J., Kadiiska, M., Liu, Y., Qu, W., Mason, R., and Waalkes, M. (2000). Acute arsenic induced free radical production and oxidative stress related gene expression in mice. Toxicologist 54, 280-281.

Maity, M., Perveen, H., Dash, M., Jana, S., Khatun, S., Dey, A., Mandal, A. K., and Chattopadhyay, S. (2018). Arjunolic acid improves the serum level of vitamin B 12 and folate in the process of the attenuation of arsenic induced uterine oxidative stress. Biological trace element research 182, 78-90.

Mandal, B. K., and Suzuki, K. T. (2002). Arsenic round the world: a review. Talanta 58, 201-235.

Mandal, S., Ray, R., Chowdhury, C., Majumder, N., and Jana, T. (2013). Implication of organic matter on arsenic and antimony sequestration in sediment: evidence from Sundarban mangrove forest, India. Bulletin of environmental contamination and toxicology 90, 451-455.

Manna, P., Sinha, M., and Sil, P. C. (2008). Protection of arsenic-induced testicular oxidative stress by arjunolic acid. Redox Report 13, 67-77.

Mazumder, D. N. G., Haque, R., Ghosh, N., De, B. K., Santra, A., Chakraborti, D., and Smith, A. H. (2000). Arsenic in drinking water and the prevalence of respiratory effects in West Bengal, India. International journal of epidemiology 29, 1047-1052.

Milton, A. H., Hasan, Z., Rahman, A., and Rahman, M. (2001). Chronic arsenic poisoning and respiratory effects in Bangladesh. Journal of occupational health 43, 136-140.

Monrad, M., Ersbøll, A. K., Sørensen, M., Baastrup, R., Hansen, B., Gammelmark, A., Tjønneland, A., Overvad, K., and Raaschou-Nielsen, O. (2017). Low-level arsenic in drinking water and risk of incident myocardial infarction: A cohort study. Environmental research 154, 318-324.

Namgung, U., and Xia, Z. (2001). Arsenic induces apoptosis in rat cerebellar neurons via activation of JNK3 and p38 MAP kinases. Toxicology and applied pharmacology 174, 130-138.

Nandi, D., Patra, R., and Swarup, D. (2006). Oxidative stress indices and plasma biochemical parameters during oral exposure to arsenic in rats. Food and chemical toxicology 44, 1579-1584.

Nielsen, S., Sloth, J. J., and Hansen, E. H. (1996). Determination of ultra-trace amounts of arsenic (III) by flow-injection hydride generation atomic absorption spectrometry with on-line preconcentration by coprecipitation with lanthanum hydroxide or hafnium hydroxide. Talanta 43, 867-880.

Nordstrom, S., Beckman, L., and Nordenson, I. (1979). Occupational and environmental risks in and around a smelter in northern Sweden. VI. Congenital malformations. Hereditas 90, 297-302.

Patlolla, A. K., and Tchounwou, P. B. (2005). Serum acetyl cholinesterase as a biomarker of arsenic induced neurotoxicity in sprague-dawley rats. International Journal of Environmental Research and Public Health 2, 80-83.

Patterson, R., Vega, L., Trouba, K., Bortner, C., and Germolec, D. (2004). Arsenic-induced alterations in the contact hypersensitivity response in Balb/c mice. Toxicology and applied pharmacology 198, 434-443.

Perreault, S., Moeller, J., Patel, K., Eyler, R., Pham, T., Russell, K., and Podoltsev, N. (2016). Use of arsenic trioxide in a hemodialysis-dependent patient with relapsed acute promyelocytic leukemia. Journal of Oncology Pharmacy Practice 22, 646-651.

Porter, A. C., Fanger, G. R., and Vaillancourt, R. R. (1999). Signal transduction pathways regulated by arsenate and arsenite. Oncogene 18, 7794-7802.

Qian, Y., Castranova, V., and Shi, X. (2003). New perspectives in arsenic-induced cell signal transduction. Journal of inorganic biochemistry 96, 271-278.

Rehman, K., Fatima, F., and Akash, M. S. H. (2019). Biochemical investigation of association of arsenic exposure with risk factors of diabetes mellitus in Pakistani population and its validation in animal model. Environmental monitoring and assessment 191, 1-15.

Richter, F., Kloster, S., Wodschow, K., Hansen, B., Schullehner, J., Kristiansen, S. M., Petersen, M. M., Strandberg-Larsen, K., and Ersbøll, A. K. (2022). Maternal exposure to arsenic in drinking water and risk of congenital heart disease in the offspring. Environment international 160, 107051.

Rios, R., Zarazúa, S., Santoyo, M., Sepúlveda-Saavedra, J., Romero-Díaz, V., Jimenez, V., Pérez-Severiano, F., Vidal-Cantú, G., Delgado, J., and Jiménez-Capdeville, M. (2009). Decreased nitric oxide markers and morphological changes in the brain of arsenic-exposed rats. Toxicology 261, 68-75.

Rodrıguez, V., Carrizales, L., Mendoza, M., Fajardo, O., and Giordano, M. (2002). Effects of sodium arsenite exposure on development and behavior in the rat. Neurotoxicology and teratology 24, 743-750.

Rodrıguez, V., Jiménez-Capdeville, M. E., and Giordano, M. (2003). The effects of arsenic exposure on the nervous system. Toxicology letters 145, 1-18.

Russell, N., Burnett, A., Hills, R., Betteridge, S., Dennis, M., Jovanovic, J., Dillon, R., and Grimwade, D. (2018). Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial. Blood, The Journal of the American Society of Hematology 132, 1452-1454.

Santra, A., Das Gupta, J., De, B., Roy, B., and Guha Mazumder, D. (1999). Hepatic manifestations in chronic arsenic toxicity. Indian Journal of Gastroenterology 18, 152-155.

Sasaki, A., Oshima, Y., and Fujimura, A. (2007). An approach to elucidate potential mechanism of renal toxicity of arsenic trioxide. Experimental hematology 35, 252-262.

Schaumloffel, N., and Gebel, T. (1998). Heterogeneity of the DNA damage provoked by antimony and arsenic. Mutagenesis 13, 281-286.

Shalat, S. L., Walker, D. B., and Finnell, R. H. (1996). Role of arsenic as a reproductive toxin with particular attention to neural tube defects. Journal of toxicology and environmental health 48, 253-272.

Shi, H., Hudson, L. G., Ding, W., Wang, S., Cooper, K. L., Liu, S., Chen, Y., Shi, X., and Liu, K. J. (2004). Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. Chemical research in toxicology 17, 871-878.

Shila, S., Kokilavani, V., Subathra, M., and Panneerselvam, C. (2005). Brain regional responses in antioxidant system to α-lipoic acid in arsenic intoxicated rat. Toxicology 210, 25-36.

Simeonova, P. P., and Luster, M. I. (2000). Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms? Journal of environmental pathology, toxicology and oncology: official organ of the International Society for Environmental Toxicology and Cancer 19, 281-286.

Smith, A. H., Goycolea, M., Haque, R., and Biggs, M. L. (1998). Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. American journal of epidemiology 147, 660-669.

Tabacova, S., Baird, D., Balabaeva, L., Lolova, D., and Petrov, I. (1994). Placental arsenic and cadmium in relation to lipid peroxides and glutathione levels in maternal-infant pairs from a copper smelter area. Placenta 15, 873-881.

Tadanobu, I., Zhang, Y. F., Shigeo, M., Hiroko, S., Hiromichi, N., Hiroki, M., Yuichi, S., and Eiichi, A. (1990). The effect of arsenic trioxide on brain monoamine metabolism and locomotor activity of mice. Toxicology letters 54, 345-353.

Tapio, S., and Grosche, B. (2006). Arsenic in the aetiology of cancer. Mutation Research/Reviews in Mutation Research 612, 215-246.

Tchounwou, P. (1999). Development of public health advisories for arsenic in drinking water. Reviews on environmental health 14, 211-230.

Tchounwou, P. B., Patlolla, A. K., and Centeno, J. A. (2003). Invited reviews: carcinogenic and systemic health effects associated with arsenic exposure—a critical review. Toxicologic pathology 31, 575-588.

Tripathi, R., Raghunath, R., and Krishnamoorthy, T. (1997). Arsenic intake by the adult population in Bombay city. Science of the total environment 208, 89-95.

Trouba, K. J., Wauson, E. M., and Vorce, R. L. (2000). Sodium arsenite-induced dysregulation of proteins involved in proliferative signaling. Toxicology and applied pharmacology 164, 161-170.

Tsou, T.-C., Tsai, F.-Y., Hsieh, Y.-W., Li, L.-A., Yeh, S. C., and Chang, L. W. (2005). Arsenite induces endothelial cytotoxicity by down-regulation of vascular endothelial nitric oxide synthase. Toxicology and applied pharmacology 208, 277-284.

Tully, D. B., Collins, B. J., Overstreet, J. D., Smith, C. S., Dinse, G. E., Mumtaz, M. M., and Chapin, R. E. (2000). Effects of arsenic, cadmium, chromium, and lead on gene expression regulated by a battery of 13 different promoters in recombinant HepG2 cells. Toxicology and applied pharmacology 168, 79-90.

Vahidnia, A., Romijn, F., Van der Voet, G., and De Wolff, F. (2008). Arsenic-induced neurotoxicity in relation to toxicokinetics: Effects on sciatic nerve proteins. Chemico-biological interactions 176, 188-195.

Vahidnia, A., van der Straaten, R., Romijn, F., Van Pelt, J., van der Voet, G., and De Wolff, F. (2007). Arsenic metabolites affect expression of the neurofilament and tau genes: An in-vitro study into the mechanism of arsenic neurotoxicity. Toxicology in Vitro 21, 1104-1112.

Wang, C.-T. (1996). Concentration of arsenic, selenium, zinc, iron and copper in the urine of blackfoot disease patients at different clinical stages. European journal of clinical chemistry and clinical biochemistry 34, 493-498.

Yadav, R. S., Shukla, R. K., Sankhwar, M. L., Patel, D. K., Ansari, R. W., Pant, A. B., Islam, F., and Khanna, V. K. (2010). Neuroprotective effect of curcumin in arsenic-induced neurotoxicity in rats. Neurotoxicology 31, 533-539.

Yang, C., and Frenkel, K. (2002). Arsenic-mediated cellular signal transduction, transcription factor activation, and aberrant gene expression: implications in carcinogenesis. Journal of environmental pathology, toxicology and oncology 21.

Yih, L.-H., Peck, K., and Lee, T.-C. (2002). Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment. Carcinogenesis 23, 867-876.

Zaldivar, R. (1980). A morbid condition involving cardio-vascular, broncho-pulmonary, digestive and neural lesions in children and young adults after dietary arsenic exposure. Zentralblatt fur Bakteriologie. 1. Abt. Originale B, Hygiene, Krankenhaushygiene, Betriebshygiene, Praventive Medizin 170, 44-56.

Zaldivar, R., and Ghai, G. (1980). Clinical epidemiological studies on endemic chronic arsenic poisoning in children and adults, including observations on children with high-and low-intake of dietary arsenic. Zentralblatt fur Bakteriologie, 1B 170, 409-421.

Zamir, E., and Geiger, B. (2001). Components of cell-matrix adhesions. Journal of cell science 114, 3577-3579.

Zarazúa, S., Pérez-Severiano, F., Delgado, J. M., Martínez, L. M., Ortiz-Pérez, D., and Jiménez-Capdeville, M. E. (2006). Decreased nitric oxide production in the rat brain after chronic arsenic exposure. Neurochemical research 31, 1069-1077.